Opportunities and Challenges in Mechanochemical Cocrystallization toward Scaled-Up Pharmaceutical Manufacturing
暂无分享,去创建一个
[1] H. Titi,et al. SpeedMixing: Rapid Tribochemical Synthesis and Discovery of Pharmaceutical Cocrystals without Milling or Grinding Media. , 2022, Angewandte Chemie.
[2] B. Sarma,et al. Crystal Engineering of Pharmaceutical Cocrystals in the Discovery and Development of Improved Drugs. , 2022, Chemical reviews.
[3] S. Spatari,et al. Mechanochemistry Can Reduce Life Cycle Environmental Impacts of Manufacturing Active Pharmaceutical Ingredients , 2022, ACS Sustainable Chemistry & Engineering.
[4] Jian-rong Wang,et al. Superior Dissolution Behavior and Bioavailability of Pharmaceutical Cocrystals and Recent Regulatory Issues. , 2021, ACS medicinal chemistry letters.
[5] C. Sandaruwan,et al. Mechanochemical Synthesis of Polymorphic Urea ⋅ Adipic Acid Cocrystal as a Sustained-Release Nitrogen Source. , 2021, ChemSusChem.
[6] Ranjit Thakuria,et al. Mechanosynthesis, Characterization, and Physicochemical Property Investigation of a Favipiravir Cocrystal with Theophylline and GRAS Coformers , 2021, Crystal Growth & Design.
[7] Ranjit Thakuria,et al. Mechanosynthesis of Eutectics of Anti‐Inflammatory Drug Ethenzamide – A Comparison with Analogous Cocrystals , 2021, Chemistry–Methods.
[8] M. Zaworotko,et al. Screening and Preparation of Cocrystals: A Comparative Study of Mechanochemistry vs Slurry Methods , 2021, Crystal growth & design.
[9] J. M. Germán-Acacio,et al. Mechanochemistry: A Green Approach in the Preparation of Pharmaceutical Cocrystals , 2021, Pharmaceutics.
[10] Evelina Colacino,et al. Upscaling Mechanochemistry: Challenges and Opportunities for Sustainable Industry , 2021 .
[11] D. Douroumis,et al. Continuous Manufacture and Scale-Up of Theophylline-Nicotinamide Cocrystals , 2021, Pharmaceutics.
[12] H. Samsodien,et al. Pharmaceutical co‐crystal: An alternative strategy for enhanced physicochemical properties and drug synergy , 2021 .
[13] B. Likozar,et al. Continuous Crystallization Processes in Pharmaceutical Manufacturing: A Review , 2020, Organic Process Research & Development.
[14] Mori Dhaval,et al. Twin-Screw Extruder in Pharmaceutical Industry: History, Working Principle, Applications, and Marketed Products: an In-depth Review , 2020, Journal of Pharmaceutical Innovation.
[15] P. Panzade,et al. Pharmaceutical cocrystal: a game changing approach for the administration of old drugs in new crystalline form , 2020, Drug development and industrial pharmacy.
[16] Giovana Carolina Bazzo,et al. Eutectic mixtures as an approach to enhance solubility, dissolution rate and oral bioavailability of poorly water-soluble drugs. , 2020, International journal of pharmaceutics.
[17] F. Delogu,et al. Solvent-Free, Continuous Synthesis of Hydrazone-Based Active Pharmaceutical Ingredients by Twin-Screw Extrusion , 2020 .
[18] A. Nangia,et al. Can We Identify the Salt–Cocrystal Continuum State Using XPS? , 2020 .
[19] Kunn Hadinoto,et al. Continuous crystallization as a downstream processing step of pharmaceutical proteins: A review , 2020 .
[20] Tejender S. Thakur,et al. Crystalline Multicomponent Solids: An Alternative for Addressing the Hygroscopicity Issue in Pharmaceutical Materials , 2020 .
[21] C. C. Seaton,et al. Improving Stability of Effervescent Products by Co-Crystal Formation: A Novel Application of Crystal Engineered Citric Acid , 2020 .
[22] F. Zhang,et al. Polymer-Assisted Aripiprazole-Adipic Acid Cocrystals Produced by Hot Melt Extrusion Techniques. , 2020, Crystal growth & design.
[23] P. McArdle,et al. Influence of Excipients on Cocrystal Stability and Formation , 2020, Crystal Growth & Design.
[24] S. Kamath,et al. Pharmaceutical Co-Crystallization: Regulatory Aspects, Design, Characterization, and Applications , 2020, Advanced pharmaceutical bulletin.
[25] Srinivas Lankalapalli,et al. Insight into Concept and Progress on Pharmaceutical Co-Crystals: An overview , 2019, Indian Journal of Pharmaceutical Education and Research.
[26] Venu R. Vangala,et al. Pharmaceutical Cocrystals: Molecules, Crystals, Formulations, Medicines , 2019, Crystal Growth & Design.
[27] F. Emmerling,et al. Tuning the Apparent Stability of Polymorphic Cocrystals through Mechanochemistry , 2019, Crystal Growth & Design.
[28] C. Muehlenfeld,et al. Scale-Up of pharmaceutical Hot-Melt-Extrusion: Process optimization and transfer. , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[29] Q. Yin,et al. Preparation of Theophylline-Benzoic Acid Cocrystal and On-Line Monitoring of Cocrystallization Process in Solution by Raman Spectroscopy , 2019, Crystals.
[30] Venkata Raman Kallakunta,et al. An update on the contribution of hot-melt extrusion technology to novel drug delivery in the twenty-first century: part I , 2019, Expert opinion on drug delivery.
[31] P. A. Shah,et al. Natural biodegradable polymers based nano‐formulations for drug delivery: A review , 2019, International journal of pharmaceutics.
[32] Fernando Gomollón-Bel. Ten Chemical Innovations That Will Change Our World: IUPAC identifies emerging technologies in Chemistry with potential to make our planet more sustainable , 2019, Chemistry International.
[33] G. Walker,et al. Pharmaceutical cocrystals: from serendipity to design to application. , 2019, Drug discovery today.
[34] M. Eddleston,et al. Cocrystal Dissociation under Controlled Humidity: A Case Study of Caffeine–Glutaric Acid Cocrystal Polymorphs , 2019, Organic Process Research & Development.
[35] J. Pluta,et al. Continuous, one‐step synthesis of pharmaceutical cocrystals via hot melt extrusion from neat to matrix‐assisted processing – State of the art , 2019, International journal of pharmaceutics.
[36] R. Suryanarayanan,et al. Role of Coformer and Excipient Properties on the Solid-State Stability of Theophylline Cocrystals , 2019, Crystal Growth & Design.
[37] I. Dejanović,et al. Control of Pharmaceutical Cocrystal Polymorphism on Various Scales by Mechanochemistry: Transfer from the Laboratory Batch to the Large-Scale Extrusion Processing , 2018, ACS Sustainable Chemistry & Engineering.
[38] Xiaonan Wang,et al. Biocatalytic Continuous Manufacturing of Diabetes Drug: Plantwide Process Modeling, Optimization, and Environmental and Economic Analysis , 2018, ACS Sustainable Chemistry & Engineering.
[39] G. Walker,et al. Pharmaceutical Cocrystal Drug Products: An Outlook on Product Development. , 2018, Trends in pharmacological sciences.
[40] A. Nangia,et al. Cocrystals, Salts, and Supramolecular Gels of Nonsteroidal Anti-Inflammatory Drug Niflumic Acid , 2018, Crystal Growth & Design.
[41] M. Jug,et al. Grinding as Solvent-Free Green Chemistry Approach for Cyclodextrin Inclusion Complex Preparation in the Solid State , 2018, Pharmaceutics.
[42] Tejender S. Thakur,et al. Preparation of Pyrazinamide Eutectics versus Cocrystals Based on Supramolecular Synthon Variations , 2018, Crystal Growth & Design.
[43] P. Ricci,et al. Processing and Investigation Methods in Mechanochemical Kinetics , 2018, ACS omega.
[44] Gavin Walker,et al. Creating Cocrystals: A Review of Pharmaceutical Cocrystal Preparation Routes and Applications , 2018, Crystal Growth & Design.
[45] Marisa Rodrigues,et al. Pharmaceutical cocrystallization techniques. Advances and challenges , 2018, International journal of pharmaceutics.
[46] M. Lusi. Engineering crystal properties through solid solutions , 2018 .
[47] Qiming Wang,et al. Continuous Manufacturing of Cocrystals Using Solid State Shear Milling Technology , 2018 .
[48] Ranjit Thakuria,et al. Drug‑Drug and Drug‑Nutraceutical Cocrystal/Salt as Alternative Medicine for Combination Therapy: A Crystal Engineering Approach , 2018 .
[49] David S. Jones,et al. Mechanochemical Synthesis of Pharmaceutical Cocrystal Suspensions via Hot Melt Extrusion: Enhancing Cocrystal Yield. , 2017, Molecular pharmaceutics.
[50] G. Zografi,et al. Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability. , 2018, Journal of pharmaceutical sciences.
[51] R. Suryanarayanan,et al. Mechanistic Insight into Caffeine-Oxalic Cocrystal Dissociation in Formulations: Role of Excipients. , 2017, Molecular pharmaceutics.
[52] G. Zografi,et al. Solid-State Properties of Pharmaceutical Materials , 2017 .
[53] T. Friščić,et al. Chemistry 2.0: Developing a New, Solvent-Free System of Chemical Synthesis Based on Mechanochemistry , 2017, Synlett.
[54] Dennis Douroumis,et al. Advanced methodologies for cocrystal synthesis , 2017, Advanced drug delivery reviews.
[55] William Jones,et al. Screening for new pharmaceutical solid forms using mechanochemistry: A practical guide☆ , 2017, Advanced drug delivery reviews.
[56] K. Nagapudi,et al. High-throughput screening and scale-up of cocrystals using resonant acoustic mixing. , 2017, International journal of pharmaceutics.
[57] F. Emmerling,et al. Impact Is Important—Systematic Investigation of the Influence of Milling Balls in Mechanochemical Reactions , 2017 .
[58] F. Emmerling,et al. Knowing When To Stop—Trapping Metastable Polymorphs in Mechanochemical Reactions , 2017 .
[59] A. Bansal,et al. Challenges in Translational Development of Pharmaceutical Cocrystals. , 2017, Journal of pharmaceutical sciences.
[60] T. Friščić,et al. Advances in Solid-State Transformations of Coordination Bonds: From the Ball Mill to the Aging Chamber , 2017, Molecules.
[61] Tomislav Friščić,et al. Mechanochemistry: A Force of Synthesis , 2016, ACS central science.
[62] D. Gadade,et al. Pharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and Development. , 2016, Advanced pharmaceutical bulletin.
[63] David S. Jones,et al. Mechanochemical Synthesis of Pharmaceutical Cocrystal Suspensions via Hot Melt Extrusion: Feasibility Studies and Physicochemical Characterization. , 2016, Molecular pharmaceutics.
[64] W. Jones,et al. Mechanochemical Synthesis of Multicomponent Crystals: One Liquid for One Polymorph? A Myth to Dispel , 2016 .
[65] N. Rodríguez-Hornedo,et al. Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5. , 2016, Advanced drug delivery reviews.
[66] Dennis Douroumis,et al. Continuous Manufacturing of High Quality Pharmaceutical Cocrystals Integrated with Process Analytical Tools for In-Line Process Control , 2016 .
[67] J. H. T. Horst,et al. Solvates, Salts, and Cocrystals: A Proposal for a Feasible Classification System , 2016 .
[68] W. Jones,et al. Polymer-Assisted Grinding, a Versatile Method for Polymorph Control of Cocrystallization , 2016 .
[69] Dimitrios I. Gerogiorgis,et al. Plantwide design and economic evaluation of two Continuous Pharmaceutical Manufacturing (CPM) cases: Ibuprofen and artemisinin , 2015, Comput. Chem. Eng..
[70] H. Abdel-Hady,et al. Caffeine therapy in preterm infants. , 2015, World journal of clinical pediatrics.
[71] Rumana Parveen,et al. Easy Access to Supramolecular Gels of the Nonsteroidal Anti-inflammatory Drug Diflunisal: Synthesis, Characterization, and Plausible Biomedical Applications. , 2015, Chemistry, an Asian journal.
[72] R. Censi,et al. Polymorph Impact on the Bioavailability and Stability of Poorly Soluble Drugs , 2015, Molecules.
[73] D. Voinovich,et al. Cocrystal Formation through Mechanochemistry: from Neat and Liquid-Assisted Grinding to Polymer-Assisted Grinding. , 2015, Angewandte Chemie.
[74] K. Harris,et al. Discovery of New Metastable Polymorphs in a Family of Urea Co-Crystals by Solid-State Mechanochemistry , 2015 .
[75] G. Desiraju,et al. Cocrystals of Hydrochlorothiazide: Solubility and Diffusion/Permeability Enhancements through Drug-Coformer Interactions. , 2015, Molecular pharmaceutics.
[76] E. Wright,et al. Probing SGLT2 as a therapeutic target for diabetes: Basic physiology and consequences , 2015, Diabetes & vascular disease research.
[77] J. Khinast,et al. Nano-extrusion: a promising tool for continuous manufacturing of solid nano-formulations. , 2014, International journal of pharmaceutics.
[78] S. Jana,et al. Exploiting supramolecular synthons in designing gelators derived from multiple drugs. , 2014, Chemistry.
[79] M. Eddleston,et al. An investigation of the causes of cocrystal dissociation at high humidity. , 2014, Journal of pharmaceutical sciences.
[80] M. Eddleston,et al. Cocrystal dissociation in the presence of water: a general approach for identifying stable cocrystal forms. , 2014, Journal of pharmaceutical sciences.
[81] T. Rades,et al. Refining stability and dissolution rate of amorphous drug formulations , 2014, Expert opinion on drug delivery.
[82] Teresa W. Makowski,et al. Commercial Route Research and Development for SGLT2 Inhibitor Candidate Ertugliflozin , 2014 .
[83] N. Rodríguez-Hornedo,et al. Pharmaceutical cocrystals and poorly soluble drugs. , 2013, International journal of pharmaceutics.
[84] Gary Montague,et al. Risk-based decision making in early chemical process development of pharmaceutical and fine chemical industries , 2013, Comput. Chem. Eng..
[85] Jonathan W Steed,et al. The role of co-crystals in pharmaceutical design. , 2013, Trends in pharmacological sciences.
[86] Robin D. Rogers,et al. Understanding the Effects of Ionicity in Salts, Solvates, Co-Crystals, Ionic Co-Crystals, and Ionic Liquids, Rather than Nomenclature, Is Critical to Understanding Their Behavior , 2013 .
[87] M. Eddleston,et al. Cocrystal dissociation and molecular demixing in the solid state. , 2012, Chemical communications.
[88] Atsushi Noda,et al. Discovery of Ipragliflozin (ASP1941): a novel C-glucoside with benzothiophene structure as a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitus. , 2012, Bioorganic & medicinal chemistry.
[89] Gargi Mukherjee,et al. Polymorphs, Salts, and Cocrystals: What’s in a Name? , 2012 .
[90] George Zografi,et al. Assessing the performance of amorphous solid dispersions. , 2012, Journal of pharmaceutical sciences.
[91] A. Nangia,et al. Fast dissolving eutectic compositions of two anti-tubercular drugs , 2012 .
[92] P. Karpiński,et al. LCZ696: a dual-acting sodium supramolecular complex , 2012 .
[93] Chuanbin Wu,et al. Improving the Chemical Stability of Amorphous Solid Dispersion with Cocrystal Technique by Hot Melt Extrusion , 2012, Pharmaceutical Research.
[94] D. Braga,et al. Ionic Co-crystals of Organic Molecules with Metal Halides: A New Prospect in the Solid Formulation of Active Pharmaceutical Ingredients , 2011 .
[95] Sarah L Price,et al. Computational prediction of salt and cocrystal structures--does a proton position matter? , 2011, International journal of pharmaceutics.
[96] C. Strachan,et al. Investigation of the Formation Process of Two Piracetam Cocrystals during Grinding , 2011, Pharmaceutics.
[97] K. Nagapudi,et al. Application of Twin Screw Extrusion in the Manufacture of Cocrystals, Part I: Four Case Studies , 2011, Pharmaceutics.
[98] Miranda L. Cheney,et al. Coformer selection in pharmaceutical cocrystal development: a case study of a meloxicam aspirin cocrystal that exhibits enhanced solubility and pharmacokinetics. , 2011, Journal of pharmaceutical sciences.
[99] William Jones,et al. Benefits of cocrystallisation in pharmaceutical materials science: an update , 2010, The Journal of pharmacy and pharmacology.
[100] P. York,et al. Cocrystalization and Simultaneous Agglomeration Using Hot Melt Extrusion , 2010, Pharmaceutical Research.
[101] K. Nagapudi,et al. Manufacture of pharmaceutical co-crystals using twin screw extrusion: a solvent-less and scalable process. , 2010, Journal of pharmaceutical sciences.
[102] D. Good,et al. Cocrystal Eutectic Constants and Prediction of Solubility Behavior , 2010 .
[103] R. Suryanarayanan,et al. Local mobility in amorphous pharmaceuticals--characterization and implications on stability. , 2009, Journal of pharmaceutical sciences.
[104] Naír Rodríguez-Hornedo,et al. Understanding and Predicting the Effect of Cocrystal Components and pH on Cocrystal Solubility , 2009 .
[105] P. Karamertzanis,et al. Salt or Cocrystal? A New Series of Crystal Structures Formed from Simple Pyridines and Carboxylic Acids , 2009 .
[106] R. Tan,et al. Dimorphs of a 1 : 1 cocrystal of ethenzamide and saccharin: solid-state grinding methods result in metastable polymorph , 2009 .
[107] A. Newman,et al. Pharmaceutical Cocrystals and Their Physicochemical Properties , 2009, Crystal growth & design.
[108] C. C. Seaton,et al. Applying Hot-Stage Microscopy to Co-Crystal Screening: A Study of Nicotinamide with Seven Active Pharmaceutical Ingredients , 2008 .
[109] Seik Weng Ng,et al. Unprecedented sodium–oxygen clusters in the solid-state structure of trisodium hydrogentetravalproate monohydrate: A model for the physiological activity of the anticonvulsant drug Epilim® , 2008 .
[110] Andrew D. Bond,et al. What is a co-crystal? , 2007 .
[111] T. Friščić,et al. Screening for pharmaceutical cocrystal hydrates via neat and liquid-assisted grinding. , 2007, Molecular pharmaceutics.
[112] Aeri Park,et al. The salt-cocrystal continuum: the influence of crystal structure on ionization state. , 2007, Molecular pharmaceutics.
[113] Matthew L Peterson,et al. Celecoxib:nicotinamide dissociation: using excipients to capture the cocrystal's potential. , 2007, Molecular pharmaceutics.
[114] Ivan Marziano,et al. Critical assessment of pharmaceutical processes--A rationale for changing the synthetic route. , 2006, Chemical reviews.
[115] Julie M. Schoenung,et al. Technical Cost Modeling for the Mechanical Milling at Cryogenic Temperature (Cryomilling) , 2004 .
[116] I. Carabin,et al. Generally recognized as safe (GRAS): history and description. , 2004, Toxicology letters.
[117] Deliang Zhou,et al. Physical stability of amorphous pharmaceuticals: Importance of configurational thermodynamic quantities and molecular mobility. , 2002, Journal of pharmaceutical sciences.
[118] Donald C. Monkhouse,et al. Review ArticlePharmaceutical Salts , 1977 .